Offers a balanced approach to fat burning and energy
doi: 10.1016/j.ijbiomac.2024.129667 111 ZhangHJiangFCZhangJSWangWHLiLYanJK
Phase 3 data from the ATTAIN-1 trial, which evaluated 3,127 adults with obesity over 72 weeks, showed a mean weight loss of 11.2%, with more than half of participants achieving at least 10% body weight reduction
BiliBili, Douyin and Xiaohongshu as health information platforms for stroke: evaluating information quality and content
The percentage of participants achieving a body weight reduction of 5% or more was 85% for the 5 mg dose, 89% for the 10 mg dose, and 91% for the 15 mg dose, indicating the potential benefits of higher doses
No established human cycling, combination, or protocol data exist for this compound